Renato Skerlj News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development

Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of massachusettsRenato skerljSudhir raoUniversity of massachusetts cancer centerBusiness development for genocea biosciencesDepartment of target discovery bioinformaticsIronwood pharmaceuticalsMerck coRd transactions at takeda pharmaceuticalsExpansion therapeutics incResearch program leaderUniversity of virginiaQuestrom school of business at boston universityCytomed incSenior research biologist

VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs

VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRedwood cityCity ofUnited kingdomSan franciscoBiree andemariamPerumal gandhiNick nieslanikShahram hejaziBarbara schilbergRobert igerAryan pandyaAlpha edisonTheresa tribbleNorthpond adam wieschhaus

Expansion Therapeutics Raises $80M in Series B Financing

Expansion Therapeutics Raises $80M in Series B Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United statesRenato skerljKleiner perkinsMatthewd disneyExpansion therapeutics incScripps researchNovartis venture fundExpansion therapeuticsCormorant asset managementWestlake village biopartnersSurveyor capitalLogos capitalSanofi venturesNovartis ventureChief executive officer

Expansion Therapeutics Names Valerie Cullen, Ph D , Senior Vice President of Research

Published: May 06, 2021 BOSTON (BUSINESS WIRE) Expansion Therapeutics., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the appointment of Valerie Cullen, Ph.D., to Senior Vice President of Research. “Valerie’s depth and breadth of research experience in drug development for neurological diseases, including leading complex programs at the intersection of research, translation and clinical development, will be tremendously valuable to our company,” said Renato Skerlj, Chief Executive Officer and President of Expansion Therapeutics. “We are fortunate to have her leadership as we advance our portfolio of small molecule medicines to treat RNA-mediated diseases in patients who currently have limited or no treatment options.”

United statesCity ofUnited kingdomProclara biosciencesValerie cullenRenato skerljMatthewd disneyScripps research instituteKing college londonProgram lead at lysosomal therapeutics incUniversity college dublinHarvard medical schoolSenior vice presidentChief executive officerVice presidentProgram lead